ZVELT THERAPEUTICS INC.

Marble Cliff, OH · Biotech · Private

Recombinant AAV gene therapy vector (Rec2-leptin) for leptin replacement in lipodystrophy

Grants
$1.3M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel Adipose Targeted Gene Therapy for Lipodystrophy$293,842
Federal grantDepartment of Health and Human Services · Phase II · Novel Adipose Targeted Gene Therapy for Lipodystrophy$974,604
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2698MC1R VENTURES LLC——
2699SpinCeutica, Inc.——
2700VOVA IDA THERAPEUTICS INC——
2701ZVELT THERAPEUTICS INC.——
2702DUB THERAPEUTICS INC.——
2703EDI THERAPEUTICS LLC——
2704OSEM FLUIDICS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.